CYP3A4 and CYP3A5 catalyse the conversion of the N-methyl-D-aspartate (NMDA) antagonist CJ-036878 to two novel dimers.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2007-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/00498250701658304PMID 17943661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complex reactions catalyzed by cytochrome P450 enzymes.

  2007cited by this paper
• Enzymatic characteristics of CYP3A5 and CYP3A4: A comparison of in vitro kinetic and drug–drug interaction patterns

  2006cited by this paper
• First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives.

  2005cited by this paper
• Binding of Two Flaviolin Substrate Molecules, Oxidative Coupling, and Crystal Structure of Streptomyces coelicolor A3(2) Cytochrome P450 158A2*

  2005cited by this paper
• Glutamate receptors and persistent pain: targeting forebrain NR2B subunits.

  2002cited by this paper
• (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.

  2002cited by this paper
• Summary of information on human CYP enzymes: human P450 metabolism data

  2002cited by this paper
• Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

  2001cited by this paper
• In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.

  2000cited by this paper
• Cytochrome P-450 3A4: regulation and role in drug metabolism.

  1999cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals.

  1996cited by this paper
• Clinical importance of hepatic cytochrome P450 in drug metabolism.

  1995cited by this paper
• Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site.

  1994cited by this paper
• Extrahepatic Metabolism of Drugs in Humans

  1994cited by this paper
• The purification and characterization of a unique cytochrome P-450 enzyme from Berberis stolonifera plant cell cultures.

  1993cited by this paper

• Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism

  2025influential citation
• Free radical metabolism of raloxifene in human liver microsomes

  2012influential citation
• Mechanisms of Cytochrome P450‐Mediated Reactions

  2012cites this paper
• Comparison of the Contributions of Cytochromes P450 3A4 and 3A5 in Drug Oxidation Rates and Substrate Inhibition

  2010influential citation